Announcements and Circulars-宜明昂科英文

Investor Relations

Information Disclosure

Announcements and Circulars Analyst Report Financial Reports Listing Documents

VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PAH TRIAL AND COMPLETION OF ENROLMENT FOR SAD AND MAD COHORTS FOR IMC-003

VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PAH TRIAL AND COMPLETION OF ENROLMENT FOR SAD AND MAD COHORTS FOR IMC-003

VOLUNTARY ANNOUNCEMENT - APPROVAL OF IND APPLICATION OF IMM0306 FOR PHASE Ib/II CLINICAL TRIAL FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS BY THE FDA

VOLUNTARY ANNOUNCEMENT - APPROVAL OF IND APPLICATION OF IMM0306 FOR PHASE Ib/II CLINICAL TRIAL FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS BY THE FDA

DATE OF BOARD MEETING

VOLUNTARY ANNOUNCEMENT - ENTERING INTO THE CAPITAL INCREASE OF A SUBSIDIARY

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July, 2026

SUPPLEMENTAL ANNOUNCEMENT - DEEMED DISPOSAL IN RELATION TO CAPITAL INCREASE OF A SUBSIDIARY

Next Day Disclosure Return

Next Day Disclosure Return

Next Day Disclosure Return

Next Day Disclosure Return

VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE II/III CLINICAL TRIAL OF IMM0306 FOR THE TREATMENT OF IgG4-RELATED DISEASE

Next Day Disclosure Return

Next Day Disclosure Return

Next Day Disclosure Return

Next Day Disclosure Return

(Revised) Next Day Disclosure Returns

ANNOUNCEMENT PURSUANT TO RULES 14A.36, 14A.39 AND 14A.46 OF THE LISTING RULES

Next Day Disclosure Return

总计 245 123 4 5 6 7 8...12 13